India Faces Rising Osteoporosis and Fracture Challenges by 2050
With the aging population, India must address the increasing burden of osteoporosis and related fractures.
By 2050, the global population aged 60+ will reach 2.1 billion, with significant implications for health care.
Osteoporosis affects millions in India, with women making up 80% of cases, leading to high fracture rates.
Biosimilars could improve access to osteoporosis treatments, addressing affordability and adherence issues.
India is confronting a significant health challenge as the population ages, particularly concerning osteoporosis and its associated fractures. By 2050, the global demographic of individuals aged 60 and older is expected to double, reaching 2.1 billion, with a substantial portion residing in emerging economies like India. This demographic shift will likely lead to an increase in age-related health issues, particularly osteoporosis, a condition that weakens bones and increases fracture risk.
Osteoporosis is often referred to as a 'silent disease' because it can progress without noticeable symptoms, leading many individuals to discover their condition only after suffering a fracture. The implications of such fractures are profound, affecting mobility and independence. Alarmingly, only about one-third of those who experience a hip fracture regain their previous level of function, underscoring the need for early diagnosis and preventive measures.
The Osteoporosis Society of India (OSI) highlights the severity of the situation, reporting that approximately 230 million individuals aged 50 and above are affected by osteopenia, with osteoporosis impacting between 8.5% and 24.6% of men and 8% to 62% of women in various age groups. An estimated 61 million Indians currently live with osteoporosis, with women constituting nearly 80% of these cases. The condition appears to develop earlier in Indians compared to Western populations, contributing to a fracture burden of over 250,000 hip fractures annually and affecting more than 4.5 million women over 60 with spinal fractures.
Despite the availability of treatment options, osteoporosis remains undertreated due to various challenges, including strict dosing requirements and potential side effects of traditional therapies, which can lead to high discontinuation rates. Biologic therapies have emerged as alternatives, offering less frequent dosing; however, access remains a significant barrier. Biosimilars, which are cost-effective alternatives to biologic treatments, could enhance access to osteoporosis care, allowing more patients to receive necessary therapies.
To effectively combat the growing osteoporosis crisis, a multifaceted approach is essential. This includes promoting awareness, ensuring timely diagnosis, and providing access to effective treatments. By integrating good nutrition, regular physical activity, and individualized treatment plans, the healthcare system can better support individuals in maintaining bone health and reducing fracture risks. As the burden of osteoporosis escalates, prioritizing early intervention and comprehensive care pathways will be crucial for improving the quality of life for millions of Indians as they age.
